Opsoclonus and ocular flutter: evaluation and management.


Journal

Current opinion in ophthalmology
ISSN: 1531-7021
Titre abrégé: Curr Opin Ophthalmol
Pays: United States
ID NLM: 9011108

Informations de publication

Date de publication:
01 Nov 2023
Historique:
medline: 28 9 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: ppublish

Résumé

Opsoclonus and ocular flutter are saccadic intrusions characterized by spontaneous, back-to-back, fast eye movements (saccades) that oscillate about the midline of central visual fixation without intervening inter-saccadic intervals. When this type of movement occurs exclusively in the horizontal plane, it is called ocular flutter. When it occurs in multiple planes (i.e. horizontal, vertical, and torsional) it is called opsoclonus. The most common etiologic categories are parainfectious and paraneoplastic diseases. Less common are toxic-metabolic, traumatic, or idiopathic origins. The mechanism of these movements relates to dysfunction of brainstem and cerebellar machinery involved in the generation of saccades. In this review, we discuss the characteristics of opsoclonus and ocular flutter, describe approaches to clinical evaluation and management of the patient with opsoclonus and ocular flutter, and review approaches to therapeutic intervention. Recent publications demonstrated eye position-dependent opsoclonus present only in left gaze, which may be related to dysfunction of frontal eye fields or structures in the cerebellar vermis. Opsoclonus and ocular flutter originate from a broad array of neuropathologies and have value from both a neuroanatomic and etiologic perspective.

Identifiants

pubmed: 37603546
doi: 10.1097/ICU.0000000000000998
pii: 00055735-990000000-00115
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-469

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Références

Zee DS, Robinson DA. A hypothetical explanation of saccadic oscillations. Ann Neurol 1979; 5:405–414.
Foroozan R, Brodsky MC. Microsaccadic opsoclonus: an idiopathic cause of oscillopsia and episodic blurred vision. Am J Ophthalmol 2004; 138:1053–1054.
Schon F, Hodgson TL, Mort D, Kennard C. Ocular flutter associated with a localized lesion in the paramedian pontine reticular formation. Ann Neurol 2001; 50:413–416.
Helmchen C, Rambold H, Sprenger A, et al. f MRIs. Cerebellar activation in opsoclonus: an fMRI study. Neurology 2003; 61:412–415.
Wong A. An update on opsoclonus. Curr Opin Neurol 2007; 20:25–31.
Kaneko CR. Effect of ibotenic acid lesions of the omnipause neurons on saccadic eye movements in rhesus macaques. J Neurophysiol 1996; 75:2229–2242.
Wong AM, Musallam S, Tomlinson RD, et al. Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 2001; 189:71–81.
Optican LM, Pretegiani E. A GABAergic dysfunction in the Olivary-Cerebellar-Brainstem Network may cause eye oscillations and body tremor. II. Model simulations of saccadic eye oscillations. Front Neurol 2017; 8:372.
Shaikh AG, Ramat S, Optican LM, et al. Saccadic burst cell membrane dysfunction is responsible for saccadic oscillations. J Neuroophthalmol 2008; 28:329–336.
Blaes F, Fühlhuber V, Korfei M, et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 2005; 58:313–317.
Bataller L, Rosenfeld MR, Graus F, et al. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 2003; 53:347–353.
Waisbourd M, Kesler A. Postinfectious ocular flutter. Neurology 2009; 72:1027.
Marsili L, Marcucci S, LaPorta J, et al. Paraneoplastic neurological syndromes of the central nervous system: pathophysiology, diagnosis, and treatment. Biomedicines 2023; 11:1406.
Guedes BF, Vieira Filho MAA, Listik C, et al. HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review. J Neurovirol 2018; 24:123–127.
Karam E, Giraldo J, Rodriguez F, et al. Ocular flutter following Zika virus infection. J Neurovirol 2017; 23:932–934.
Mahale RR, Mehta A, Buddaraju K, Srinivasa R. Parainfectious ocular flutter and truncal ataxia in association with dengue fever. J Pediatr Neurosci 2017; 12:91–92.
Gyllenborg J, Milea D. Ocular flutter as the first manifestation of Lyme disease. Neurology 2009; 72:291.
Dubbioso R, Marcelli V, Manganelli F, et al. Anti-GAD antibody ocular flutter: expanding the spectrum of autoimmune ocular motor disorders. J Neurol 2013; 260:2675–2677.
Zaro-Weber O, Galldiks N, Dohmen C, et al. Ocular flutter, generalized myoclonus, and trunk ataxia associated with anti-GQ1b antibodies. Arch Neurol 2008; 65:659–661.
Merati M, Rucker JC, McKeon A, et al. A case of opsoclonus-myoclonus-ataxia with neuronal intermediate filament IgG detected in cerebrospinal fluid. J Neuroophthalmol 2022; 42:278–281.
Digre KB. Opsoclonus in adults. Report of three cases and review of the literature. Arch Neurol 1986; 43:1165–1175.
Blaes F. Paraneoplastic brain stem encephalitis. Curr Treat Options Neurol 2013; 15:201–209.
Turazzi S, Alexandre A, Bricolo A, Rizzuto N. Opsoclonus and palatal myoclonus during prolonged posttraumatic coma. A clinico-pathologic study. Eur Neurol 1977; 15:257–263.
Manta A, Ugradar S, Theodorou M. Ocular flutter after mild head trauma. J Neuroophthalmol 2018; 38:476–478.
Rizzo JR, Hudson TE, Sequeira AJ, et al. Eye position-dependent opsoclonus in mild traumatic brain injury. Prog Brain Res 2019; 249:65–78.
Yuen TJ, Browne KD, Iwata A. Sodium channelopathy induced by mild axonal trauma worsens outcome after a repeat injury. J Neurosci Res 2009; 87:3620–3625.
Liang TW, Balcer LJ, Solomon D, et al. Supranuclear gaze palsy and opsoclonus after Diazinon poisoning. J Neurol Neurosurg Psychiatry 2003; 74:677–679.
Changa AR, Rucker JC, Drummond PS. Opsoclonus in uremia with resolution after hemodialysis. J Neuroophthalmol 2022; 42:e448–e449.
Klaas JP, Ahlskog JE, Pittock SJ, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol 2012; 69:1598–1607.
Moe PG, Nellhaus G. Infantile polymyoclonia-opsoclonus syndrome and neural crest tumors. Neurology 1970; 20:756–764.
Pranzatelli MR, Tate ED, McGee NR. Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol 2017; 8:468.
Pranzatelli MR. The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1992; 15:186–228.
Fühlhuber V, Bick S, Tschernatsch M, et al. Autoantibody-mediated cytotoxicity in paediatric opsoclonus-myoclonus syndrome is dependent on ERK-1/2 phophorylation. J Neuroimmunol 2015; 289:182–186.
Korfei M, Fühlhuber V, Schmidt-Wöll T, et al. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J Neuroimmunol 2005; 170:150–157.
Yee RD, Spiegel PH, Yamada T, et al. Voluntary saccadic oscillations, resembling ocular flutter and opsoclonus. J Neuroophthalmol 1994; 14:95–101.
Nagle M, Bridgeman B, Stark L. Voluntary nystagmus, saccadic suppression, and stabilization of the visual world. Vision Res 1980; 20:717–721.
Sahu JK, Prasad K. The opsoclonus–myoclonus syndrome. Pract Neurol 2011; 11:160–166.
De Grandis E, Parodi S, Conte M, et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics 2009; 40:103–111.
Yiu VW, Kovithavongs T, McGonigle LF, Ferreira P. Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediatr Neurol 2001; 24:72–74.
Tate ED, Pranzatelli MR, Verhulst SJ, et al. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol 2012; 27:875–884.
Armstrong MB, Robertson PL, Castle VP. Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis. Pediatr Neurol 2005; 33:365–367.
Fernandes TD, Bazan R, Betting LE, da Rocha FC. Topiramate effect in opsoclonus-myoclonus-ataxia syndrome. Arch Neurol 2012; 69:133.
Shaikh AG, Zee DS, Optican LM, et al. The effects of ion channel blockers validate the conductance-based model of saccadic oscillations. Ann N Y Acad Sci 2011; 1233:58–63.

Auteurs

Scott N Grossman (SN)

Department of Neurology.

Janet C Rucker (JC)

Department of Neurology.
Department of Ophthalmology, New York University Grossman School of Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH